New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill AR43

Introduced
1/11/22  

Caption

Urges relevant State licensing boards to implement continuing education requirements on topics related to opioid pain medication.

Impact

If adopted, AR43 would effectively standardize ongoing educational requirements specific to opioid pain management across various healthcare professions. This would not only enhance the knowledge of healthcare providers regarding opioids but also significantly aim to reduce the potential for misuse and abuse of such medications. By ensuring that healthcare professionals engage in updated educational programs every two biennial periods, the resolution aims to foster safer prescribing practices and improve patient outcomes.

Summary

Assembly Resolution No. 43 (AR43) urges the State Boards of Medical Examiners, Dentistry, Nursing, and Pharmacy in New Jersey to require continuing education for healthcare professionals on topics related to opioid pain medication. This resolution emphasizes the importance of responsible prescribing practices, the availability of alternative treatments, and identifying the signs of misuse and addiction. The call for these requirements reflects an urgent response to the ongoing opioid crisis and the need for better education surrounding opioid prescriptions.

Contention

While there is substantial support for the initiative, some argue that imposing mandatory continuing education may place an additional burden on healthcare professionals. Critics may wish to raise concerns about the feasibility and scope of the proposed educational requirements, particularly in ensuring that all health care providers, including those not primarily focused on pain management, are adequately covered by these regulations. The resolution does highlight that while current credits in addiction prevention are mandated, similar requirements regarding opioids are notably absent.

Conversations

Further discussions around AR43 also emphasize the state's proactive measures to address opioid misuse, including campaigns and the New Jersey Prescription Monitoring Program. Those in favor of the resolution argue that comprehensive education on opioids is a crucial step to complement these programs, ensuring that providers have the knowledge needed to navigate the complexities of opioid prescriptions effectively.

Companion Bills

No companion bills found.

Previously Filed As

NJ SR32

Urges relevant State licensing boards to implement continuing education requirements on topics related to opioid pain medication.

NJ HF3859

Education requirements for licensure and continuing education topics in certain health-related occupations modified.

NJ HB222

County Boards of Education - Opioid Overdose-Reversing Medications - Policy Requirements (Naloxone Access Act)

NJ HB0222

County Boards of Education - Opioid Overdose-Reversing Medications - Policy Requirements (Naloxone Access Act)

NJ SF3862

Education requirements for licensure and continuing education topics in certain health-related occupations modification

NJ HB2405

Topical medications

NJ H0353

Sickle Cell Disease Treatment of Pain Continuing Education

NJ HB852

Educational Institutions - Opioid Overdose-Reversing Medications - Policy Requirements (Protecting Our Kids From Overdoses Act)

NJ HB34

Professional licensing boards; continuing education tracking solution to monitor compliance of licenses with applicable continuing education requirements; establish

NJ A2124

Requires institutions of higher education to maintain supply of opioid antidotes and permits emergency administration of opioid antidote by campus medical professional or trained employee.

Similar Bills

No similar bills found.